Biblio Discovery — Demo Discovery Service

9 hasil untuk "Simone Ragaini"

Menampilkan 1–9 · 0,20 detik · RSS

  1. Artikel Jurnal

    Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman disease: two case reports

    Simone Ferrero; Simone Ragaini

    Journal of Medical Case Reports, Vol. 15 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Human herpervirus-8/human immunodeficiency virus negative Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disorder sustained by a pro-inflammatory condition of hypercytokinemia mostly mediated by Interleukin-6 (IL-6). According to iMCD consensus…

  2. Artikel Jurnal

    Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry

    Marie-Kristin Tilch; Carlo Visco; Sandra Kinda dkk.

    HemaSphere, Vol. 6 No. 5 · 2022 · Inggris · DOAJ Scopus

    Data on outcome of patients with mantle cell lymphoma (MCL) and COVID-19 infection are limited. The European MCL (EMCL) registry is a centralized registry of the EMCL network, collecting real-world information about treatments and disease courses. During the COVID-19 pandemic, additional data on…

  3. Artikel Jurnal

    Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study

    Irene Dogliotti; Veronica Peri; Michele Clerico dkk.

    Cancer Medicine, Vol. 13 No. 14 · 2024 · Inggris · DOAJ Scopus

    Abstract Background Relapse and refractory (R/R) rates after first‐line R‐CHOP in diffuse large B cell lymphomas (DLBCL) are ~40% and ~15% respectively. Aims We conducted a retrospective real‐world analysis aimed at evaluating clinical outcomes of R/R DLBCL patients. Material and Methods Overall…

  4. Artikel Jurnal

    Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial

    Michele Clerico; Simone Ferrero; Beatrice Alessandria dkk.

    Scientific Reports, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract In the frontline high-dose phase 3 FIL-MCL0208 trial (NCT02354313), 8% of enrolled mantle cell lymphoma (MCL) patients could not be randomised to receive lenalidomide (LEN) maintenance vs observation after autologous stem cell transplantation (ASCT) due to inadequate hematological recovery…

  5. Artikel Jurnal

    Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)‐MCL0208 clinical trial

    Francesca Cordero; Simone Ferrero; Simone Pernice dkk.

    HemaSphere, Vol. 10 No. 5 · 2026 · Inggris · DOAJ Scopus

    Abstract Recent clinical trials have underscored the value of repeated minimal residual disease (MRD) measurements as a highly sensitive method for detecting subclinical disease and enabling dynamic risk stratification in hematologic malignancies. Despite its clinical potential, the complex and…

  6. Artikel Jurnal

    Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial

    Simone Ragaini; Anna Galli; Elisa Genuardi dkk.

    Blood Advances, Vol. 9 No. 8 · 2025 · Inggris · DOAJ Scopus

    Abstract: Although recent evidence suggests that myeloid clonal hematopoiesis (M-CH) may influence lymphoma clinical outcome, its impact in mantle cell lymphoma (MCL) remains unclear. Here, we report a comprehensive next-generation sequencing–based analysis of the M-CH mutational landscape at…

  7. Artikel Jurnal

    Clonal hematopoiesis dynamics influences long‐term outcomes of follicular lymphoma: Results from FIL FOLL12 trial

    Nawar Maher; Riccardo Moia; Mohammad Almasri dkk.

    HemaSphere, Vol. 10 No. 5 · 2026 · Inggris · DOAJ Scopus

    Abstract Whether clonal hematopoiesis (CH) in follicular lymphoma (FL) patients affects clinical outcome or is merely a bystander phenomenon is unclear. We leveraged the Phase III Fondazione Italiana Linfomi FOLL12 trial, which treated patients with advanced‐stage FL with R‐CHOP or R‐Bendamustine…